Grant: Planning and Dissemination Grant - Institute Community Support
University of Alberta
$6,963.00
6th Canadian Symposium on Hepatitis C Virus
FY 2016-17
Summary
The hepatitis C virus (HCV) infects over 250,000 Canadians and causes more years of life lost than any other infectious disease. The Canadian Institute for Health Research (CIHR) and the Public Health Agency of Canada have identified hepatitis C as a major public health problem. In the last two years, there were significant advances in developing drugs to treat hepatitis C, with cures in greater than 95% and very few side effects. These treatments are available in all Canadian provinces, although most only support using these drugs in patients with moderately severe fibrosis. Some countries have developed national programs to eliminate HCV. In Canada, there are financial, geographical, cultural, and social barriers that affect treatment uptake. With financial support from CIHR and non-CIHR sources, the National CIHR Research Training Program in Hepatitis C has brought together key HCV researchers and stakeholders through the annual Canadian Symposium on Hepatitis C Viruses. This unique program is a national showpiece that brings together expertise from all four pillars including discovery and social scientists, public health experts, and clinicians. The symposia are designed to improve prevention, diagnosis and therapeutic strategies at a manageable cost. This CIHR Planning and Dissemination Grant request is for support for the 6th symposium to be held on March 3, 2017 in Banff. The theme will be "Delivering a Cure for Hepatitis C Infection: What are the Remaining Gaps?" and will focus on key strategies to enhance HCV treatment, prevention, and diagnosis, and to discuss how highly effective therapies can reach difficult-to-treat populations. With HCV therapies becoming more tolerable, it is possible to treat patients in remote areas through nurse practitioners, family physicians and pharmacists. We believe the remaining gaps in delivering cures to hepatitis C patients can be filled and Canada, too, can be a country that embraces the goal of eliminating hepatitis C.
Department
Program
Planning and Dissemination Grant - Institute Community Support
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
352985
Name
Tyrrell D. Lorne J
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Planning and Dissemination - III
Projecttitle
6th Canadian Symposium on Hepatitis C Virus
Programtype2
Miscellaneous Programs
Orgnameinp2
University of Alberta
Cihramount2
$6,963
Cihrequipment2
$0
Programname2
Planning and Dissemination Grant - Institute Community Support
Keyworddelim
Disease Burden In Canada; Epidemiology; Hepatitis C Virus; Marginalized Populations; Public Health; Social Sciences; Viral Hepatitis
Abstract
The hepatitis C virus (HCV) infects over 250,000 Canadians and causes more years of life lost than any other infectious disease. The Canadian Institute for Health Research (CIHR) and the Public Health Agency of Canada have identified hepatitis C as a major public health problem. In the last two years, there were significant advances in developing drugs to treat hepatitis C, with cures in greater than 95% and very few side effects. These treatments are available in all Canadian provinces, although most only support using these drugs in patients with moderately severe fibrosis. Some countries have developed national programs to eliminate HCV. In Canada, there are financial, geographical, cultural, and social barriers that affect treatment uptake. With financial support from CIHR and non-CIHR sources, the National CIHR Research Training Program in Hepatitis C has brought together key HCV researchers and stakeholders through the annual Canadian Symposium on Hepatitis C Viruses. This unique program is a national showpiece that brings together expertise from all four pillars including discovery and social scientists, public health experts, and clinicians. The symposia are designed to improve prevention, diagnosis and therapeutic strategies at a manageable cost. This CIHR Planning and Dissemination Grant request is for support for the 6th symposium to be held on March 3, 2017 in Banff. The theme will be "Delivering a Cure for Hepatitis C Infection: What are the Remaining Gaps?" and will focus on key strategies to enhance HCV treatment, prevention, and diagnosis, and to discuss how highly effective therapies can reach difficult-to-treat populations. With HCV therapies becoming more tolerable, it is possible to treat patients in remote areas through nurse practitioners, family physicians and pharmacists. We believe the remaining gaps in delivering cures to hepatitis C patients can be filled and Canada, too, can be a country that embraces the goal of eliminating hepatitis C.
Competitiondate
201608
Approvedterm2
1 yr 0 mth
Pinamesdelim
Tyrrell, D. Lorne J
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Infection & Immunity~ $6,963~ $0~